DK1037886T3 - Triazin angiogeneseinhibitorer - Google Patents
Triazin angiogeneseinhibitorerInfo
- Publication number
- DK1037886T3 DK1037886T3 DK98963082T DK98963082T DK1037886T3 DK 1037886 T3 DK1037886 T3 DK 1037886T3 DK 98963082 T DK98963082 T DK 98963082T DK 98963082 T DK98963082 T DK 98963082T DK 1037886 T3 DK1037886 T3 DK 1037886T3
- Authority
- DK
- Denmark
- Prior art keywords
- triazine
- angiogenesis inhibitors
- compounds
- angiogenesis
- exacerbated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
- C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99011997A | 1997-12-12 | 1997-12-12 | |
US09/209,396 US6150362A (en) | 1997-12-12 | 1998-12-10 | Triazine angiogenesis inhibitors |
PCT/US1998/026369 WO1999031088A1 (fr) | 1997-12-12 | 1998-12-11 | Inhibiteurs d'angiogenese a base de triazine |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1037886T3 true DK1037886T3 (da) | 2003-08-25 |
Family
ID=26904132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98963082T DK1037886T3 (da) | 1997-12-12 | 1998-12-11 | Triazin angiogeneseinhibitorer |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1037886B1 (fr) |
JP (1) | JP2002542144A (fr) |
KR (1) | KR20010032998A (fr) |
CN (1) | CN1290264A (fr) |
AT (1) | ATE239012T1 (fr) |
AU (1) | AU1818599A (fr) |
BG (1) | BG104584A (fr) |
BR (1) | BR9813468A (fr) |
CA (1) | CA2313776A1 (fr) |
DE (1) | DE69814151T2 (fr) |
DK (1) | DK1037886T3 (fr) |
ES (1) | ES2198088T3 (fr) |
HU (1) | HUP0202076A3 (fr) |
IL (1) | IL136339A0 (fr) |
NO (1) | NO20003018L (fr) |
PL (1) | PL344861A1 (fr) |
PT (1) | PT1037886E (fr) |
SK (1) | SK8662000A3 (fr) |
TR (1) | TR200001690T2 (fr) |
WO (1) | WO1999031088A1 (fr) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6943161B2 (en) | 1999-12-28 | 2005-09-13 | Pharmacopela Drug Discovery, Inc. | Pyrimidine and triazine kinase inhibitors |
FR2804113B1 (fr) * | 2000-01-26 | 2004-06-18 | Lipha | Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique |
AR029489A1 (es) | 2000-03-10 | 2003-07-02 | Euro Celtique Sa | Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento |
WO2002076438A2 (fr) * | 2001-03-23 | 2002-10-03 | Chugai Seiyaku Kabushiki Kaisha | Ligands flt-1 et utilisations de ceux-ci |
US6864255B2 (en) | 2001-04-11 | 2005-03-08 | Amgen Inc. | Substituted triazinyl amide derivatives and methods of use |
AR037233A1 (es) | 2001-09-07 | 2004-11-03 | Euro Celtique Sa | Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento |
AR036873A1 (es) | 2001-09-07 | 2004-10-13 | Euro Celtique Sa | Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento |
US7132423B2 (en) | 2001-09-21 | 2006-11-07 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
US7163943B2 (en) | 2001-09-21 | 2007-01-16 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
EP1436266A4 (fr) * | 2001-09-21 | 2004-12-22 | Reddy Us Therapeutics Inc | Methodes et compositions faisant intervenir de nouvelles triazines |
US7112587B2 (en) | 2001-09-21 | 2006-09-26 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
US7169785B2 (en) | 2001-09-21 | 2007-01-30 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
US7173032B2 (en) | 2001-09-21 | 2007-02-06 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
EP1441683A4 (fr) | 2001-10-12 | 2005-10-26 | Univ New York | Composes de triazine trisubstitues a activite anti-tubuline, procedes d'elaboration et d'utilisation correspondants |
US20030187026A1 (en) | 2001-12-13 | 2003-10-02 | Qun Li | Kinase inhibitors |
US7015227B2 (en) | 2002-06-21 | 2006-03-21 | Cgi Pharmaceuticals, Inc. | Certain amino-substituted monocycles as kinase modulators |
AU2003245669A1 (en) * | 2002-06-21 | 2004-01-06 | Cellular Genomics, Inc. | Certain aromatic monocycles as kinase modulators |
US20050014753A1 (en) * | 2003-04-04 | 2005-01-20 | Irm Llc | Novel compounds and compositions as protein kinase inhibitors |
US7335770B2 (en) | 2004-03-24 | 2008-02-26 | Reddy U5 Therapeutics, Inc. | Triazine compounds and their analogs, compositions, and methods |
US7592451B2 (en) | 2005-06-23 | 2009-09-22 | New York University | Treatment for diabetes and obesity as well as method of screening compounds useful for such treatments |
FR2896161B1 (fr) | 2006-01-13 | 2008-04-04 | Merck Sante Soc Par Actions Si | Utilisation de derives de triazines pour fabriquer un medicament ayant un effet cicatrisant ou angiogenique. |
KR100761869B1 (ko) * | 2006-07-07 | 2007-10-04 | 김현기 | 트리아진 유도체 화합물 및 이를 포함하는 암 치료용조성물 |
DE102007054416A1 (de) * | 2007-11-13 | 2009-05-14 | Studiengesellschaft Kohle Mbh | Verfahren zur Herstellung von 3,6-Dihydro-1,3,5- Triazin-Derivaten für die Behandlungen von Erkrankungen, die mit dem Insulinresistenz-Syndrom assoziiert sind |
PT3216793T (pt) * | 2008-05-23 | 2019-05-30 | Wyeth Llc | Compostos de triazina como inibidores de pi3 quinase e mtor |
WO2015003360A2 (fr) * | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Composés thérapeutiquement actifs et leurs méthodes d'utilisation |
US9579324B2 (en) | 2013-07-11 | 2017-02-28 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
CN106632000B (zh) * | 2016-12-19 | 2019-04-26 | 湖北工业大学 | 二芳基甲酮化合物在制备抗肿瘤药物中的应用 |
EP3801542B1 (fr) | 2018-06-06 | 2022-08-10 | Poxel SA | Méthodes de traitement de sujets atteints de diabète avec une maladie rénale chronique |
WO2019238647A1 (fr) | 2018-06-14 | 2019-12-19 | Poxel | Comprimé pelliculé comprenant un dérivé de triazine destiné à être utilisé dans le traitement du diabète |
CN111686113B (zh) * | 2019-03-15 | 2022-12-30 | 北京大学 | Sonic Hedgehog抑制剂及应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2358856C3 (de) * | 1973-11-26 | 1981-05-21 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Stabilisierung wäßriger Formaldehydlösungen |
DE2919496A1 (de) * | 1979-05-15 | 1980-12-04 | Degussa | Neue bisguanamine |
US4555532A (en) * | 1983-10-14 | 1985-11-26 | Hitachi, Ltd. | Epoxy resin composition |
AU9097991A (en) * | 1990-12-20 | 1992-07-22 | Nippon Shinyaku Co. Ltd. | Anticancer composition and compound |
JPH04300874A (ja) * | 1991-03-29 | 1992-10-23 | Tsumura & Co | 新規2,4−ジアミノ−1,3,5−トリアジン誘導体 |
JPH04300832A (ja) * | 1991-03-29 | 1992-10-23 | Tsumura & Co | 2,4−ジアミノ−1,3,5−トリアジン誘導体を有 効成分とするロイコトリエン拮抗剤 |
TW328955B (en) * | 1993-05-14 | 1998-04-01 | Cytec Tech Corp | Process for preparing bis- or tris-carbamate functional 1,3,5-triazines, substantially halogen contamination free crosslinker compositions and new bis-or tris-carbamate functional 1,3,5-triazines |
DE4423138A1 (de) * | 1994-07-01 | 1996-01-04 | Hoechst Ag | Elastisches Einkomponenten-Epoxidharz-System mit hoher Lagerstabilität |
-
1998
- 1998-12-11 IL IL13633998A patent/IL136339A0/xx unknown
- 1998-12-11 PL PL98344861A patent/PL344861A1/xx unknown
- 1998-12-11 DK DK98963082T patent/DK1037886T3/da active
- 1998-12-11 BR BR9813468-0A patent/BR9813468A/pt not_active IP Right Cessation
- 1998-12-11 ES ES98963082T patent/ES2198088T3/es not_active Expired - Lifetime
- 1998-12-11 PT PT98963082T patent/PT1037886E/pt unknown
- 1998-12-11 AU AU18185/99A patent/AU1818599A/en not_active Abandoned
- 1998-12-11 SK SK866-2000A patent/SK8662000A3/sk unknown
- 1998-12-11 HU HU0202076A patent/HUP0202076A3/hu unknown
- 1998-12-11 AT AT98963082T patent/ATE239012T1/de not_active IP Right Cessation
- 1998-12-11 DE DE69814151T patent/DE69814151T2/de not_active Expired - Fee Related
- 1998-12-11 CN CN98813592A patent/CN1290264A/zh active Pending
- 1998-12-11 KR KR1020007006350A patent/KR20010032998A/ko not_active Application Discontinuation
- 1998-12-11 TR TR2000/01690T patent/TR200001690T2/xx unknown
- 1998-12-11 WO PCT/US1998/026369 patent/WO1999031088A1/fr not_active Application Discontinuation
- 1998-12-11 JP JP2000539012A patent/JP2002542144A/ja not_active Withdrawn
- 1998-12-11 CA CA002313776A patent/CA2313776A1/fr not_active Abandoned
- 1998-12-11 EP EP98963082A patent/EP1037886B1/fr not_active Expired - Lifetime
-
2000
- 2000-06-13 NO NO20003018A patent/NO20003018L/no not_active Application Discontinuation
- 2000-07-06 BG BG104584A patent/BG104584A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
BG104584A (bg) | 2001-01-31 |
NO20003018L (no) | 2000-08-04 |
WO1999031088A1 (fr) | 1999-06-24 |
TR200001690T2 (tr) | 2001-05-21 |
EP1037886A1 (fr) | 2000-09-27 |
IL136339A0 (en) | 2001-05-20 |
ES2198088T3 (es) | 2004-01-16 |
HUP0202076A2 (hu) | 2002-11-28 |
BR9813468A (pt) | 2001-11-13 |
KR20010032998A (ko) | 2001-04-25 |
EP1037886B1 (fr) | 2003-05-02 |
JP2002542144A (ja) | 2002-12-10 |
ATE239012T1 (de) | 2003-05-15 |
CN1290264A (zh) | 2001-04-04 |
CA2313776A1 (fr) | 1999-06-24 |
PL344861A1 (en) | 2001-11-19 |
PT1037886E (pt) | 2003-09-30 |
NO20003018D0 (no) | 2000-06-13 |
DE69814151T2 (de) | 2004-03-25 |
HUP0202076A3 (en) | 2003-12-29 |
DE69814151D1 (de) | 2003-06-05 |
AU1818599A (en) | 1999-07-05 |
SK8662000A3 (en) | 2001-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69814151D1 (de) | Triazin angiogenese-inhibitoren | |
BG106585A (en) | Kinase inhibitors as therapeutic agents | |
DE60114994D1 (de) | Blutplättchen-adp-rezeptor-inhibitoren | |
DE69919397D1 (de) | Thrombin-inhibitoren | |
JO2372B1 (en) | Source drugs of 4-phenylpyridine derivatives | |
CY1112024T1 (el) | Αναστολεις υποδοχεων adp αιμοπεταλιων | |
TR200201505T2 (tr) | Terapötik maddeler olarak pirazolopirimidinler | |
BG106867A (en) | Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory autoimmune and respiratory diseases | |
DE60045426D1 (de) | Phenyl-benzyl-ketone | |
ATE240328T1 (de) | Substituierte azaoxindolederivate | |
IS2125B (is) | Frumuviðloðunar-bælandi bólgu-eyðandi og ónæmisbælandi efnasambönd | |
DE69716810D1 (de) | 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one | |
CO5261493A1 (es) | Procedimiento y compuestos para la inhibicion de la mrp1 | |
ATE297904T1 (de) | Halo-alkoxycarbonylverbindungen | |
DE69933885D1 (de) | Triphenylbutenderivate zur behandlung von neurologischen störungen | |
CY1105977T1 (el) | Αντι-αγγειογονικο φαρμακο για να θepαπευεται καρκινος, αρθριτιδα και αμφιβληστροειδοπαθεια | |
TR200102514T2 (tr) | COPD tedavisi için metod | |
ATE277018T1 (de) | 3,4-dihydrochinolin-derivative als stickstoffmonoxid-synthase (nos) inhibitoren | |
AR013802A1 (es) | Inhibidores de angiogenesis de triazina | |
SI1077694T1 (en) | Aryl nitrone therapeutics for the treatment of inflammatory bowel disease |